Company Filing History:
Years Active: 1998-2008
Title: The Innovations of Philippe Bridonneau
Introduction
Philippe Bridonneau is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of biotechnology, particularly in the development of high-affinity nucleic acid ligands. With a total of 5 patents to his name, Bridonneau's work has advanced the understanding and application of oligonucleotide ligands.
Latest Patents
One of his latest patents focuses on high-affinity nucleic acid ligands to lectins. This invention discloses high-affinity oligonucleotide ligands that can bind to various lectins, including wheat germ agglutinin, L-selectin, E-selectin, and P-selectin. The patent also outlines methods for obtaining such ligands, showcasing Bridonneau's innovative approach to biotechnology.
Career Highlights
Throughout his career, Philippe Bridonneau has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Gilead Sciences, Inc. and Nexstar Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise and success as an inventor.
Collaborations
Bridonneau has collaborated with several professionals in his field, including David H Parma and Brian James Hicke. These collaborations have likely enriched his work and led to further advancements in his inventions.
Conclusion
Philippe Bridonneau's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, particularly in the development of nucleic acid ligands.